| Primary |
| Hiv Infection |
68.9% |
| Acquired Immunodeficiency Syndrome |
8.9% |
| Antiretroviral Therapy |
8.0% |
| Hiv Test Positive |
2.6% |
| Weight Decreased |
1.3% |
| Cd4 Lymphocytes Decreased |
1.1% |
| Prophylaxis |
1.1% |
| Diarrhoea |
0.9% |
| Factor Viii Deficiency |
0.9% |
| Hepatitis C |
0.9% |
| Drug Eruption |
0.7% |
| Hiv Infection Cdc Group Iv Subgroup C1 |
0.7% |
| Antifungal Prophylaxis |
0.6% |
| Mycobacterium Avium Complex Infection |
0.6% |
| Oesophageal Candidiasis |
0.6% |
| Toxoplasmosis |
0.6% |
| Urinary Tract Infection |
0.5% |
| Antibiotic Prophylaxis |
0.4% |
| Cellulitis |
0.4% |
| Pneumocystis Jiroveci Pneumonia |
0.4% |
|
| Pregnancy |
16.0% |
| Lipodystrophy Acquired |
8.0% |
| Premature Baby |
7.0% |
| Renal Failure Acute |
7.0% |
| Vomiting |
6.0% |
| Neuropathy Peripheral |
5.0% |
| Renal Disorder |
5.0% |
| Depression |
4.0% |
| Facial Wasting |
4.0% |
| Glucose Tolerance Impaired |
4.0% |
| Lactic Acidosis |
4.0% |
| Pulmonary Infarction |
4.0% |
| Stillbirth |
4.0% |
| Varices Oesophageal |
4.0% |
| Coronary Artery Disease |
3.0% |
| Diarrhoea |
3.0% |
| Lumbar Vertebral Fracture |
3.0% |
| Spinal Compression Fracture |
3.0% |
| Thrombocythaemia |
3.0% |
| Transaminases Increased |
3.0% |
|
| Secondary |
| Hiv Infection |
75.2% |
| Acquired Immunodeficiency Syndrome |
6.3% |
| Drug Use For Unknown Indication |
4.4% |
| Product Used For Unknown Indication |
2.1% |
| Antiretroviral Therapy |
1.7% |
| Hiv Test Positive |
1.4% |
| Hepatitis C |
1.1% |
| Hypertension |
0.9% |
| Haemophilia |
0.8% |
| Diabetes Mellitus |
0.8% |
| Mycobacterium Avium Complex Infection |
0.7% |
| Tuberculosis |
0.6% |
| Factor Viii Deficiency |
0.5% |
| Lymph Node Tuberculosis |
0.5% |
| Drug Exposure During Pregnancy |
0.5% |
| Atypical Mycobacterial Infection |
0.5% |
| Oral Candidiasis |
0.5% |
| Antifungal Prophylaxis |
0.4% |
| Cytomegalovirus Enterocolitis |
0.4% |
| Pneumocystis Jiroveci Pneumonia |
0.4% |
|
| Vomiting |
9.6% |
| Weight Decreased |
7.7% |
| Pulmonary Hypertension |
6.5% |
| Lipodystrophy Acquired |
5.7% |
| Hepatic Cirrhosis |
5.4% |
| Hypertriglyceridaemia |
5.4% |
| Platelet Count Decreased |
5.4% |
| Renal Impairment |
5.4% |
| Abortion Spontaneous |
4.6% |
| Hyperlipidaemia |
4.6% |
| Pancreatic Mass |
4.6% |
| Rash |
4.6% |
| Varices Oesophageal |
4.6% |
| White Blood Cell Count Decreased |
4.2% |
| Sepsis |
3.8% |
| Stillbirth |
3.8% |
| Urine Abnormality |
3.8% |
| Progressive External Ophthalmoplegia |
3.4% |
| Pyrexia |
3.4% |
| Thrombocytopenia |
3.4% |
|
| Concomitant |
| Hiv Infection |
68.6% |
| Acquired Immunodeficiency Syndrome |
4.3% |
| Drug Use For Unknown Indication |
4.3% |
| Product Used For Unknown Indication |
2.3% |
| Haemorrhoids |
1.7% |
| Factor Viii Deficiency |
1.5% |
| Diarrhoea |
1.4% |
| Hepatic Cirrhosis |
1.4% |
| Hiv Test Positive |
1.4% |
| Maternal Exposure During Pregnancy |
1.4% |
| Mycobacterium Avium Complex Infection |
1.4% |
| Hypertension |
1.3% |
| Angina Pectoris |
1.2% |
| Mitochondrial Toxicity |
1.2% |
| Prophylaxis |
1.2% |
| Depression |
1.1% |
| Lower Gastrointestinal Haemorrhage |
1.1% |
| Oral Candidiasis |
1.1% |
| Trigeminal Neuralgia |
1.0% |
| Cytomegalovirus Infection |
0.9% |
|
| White Blood Cell Count Decreased |
10.5% |
| Renal Impairment |
7.9% |
| Vomiting |
6.6% |
| Osteonecrosis |
5.9% |
| Pneumonia |
5.9% |
| Weight Decreased |
5.9% |
| Optic Neuritis Retrobulbar |
5.3% |
| Rash |
5.3% |
| Uveitis |
5.3% |
| Varices Oesophageal |
5.3% |
| Drug Exposure During Pregnancy |
3.9% |
| Pancreatic Insufficiency |
3.9% |
| Pyrexia |
3.9% |
| Renal Failure |
3.9% |
| Urinary Tract Infection |
3.9% |
| Weight Increased |
3.9% |
| Malaise |
3.3% |
| Sepsis |
3.3% |
| Thrombocytopenia |
3.3% |
| Abortion Spontaneous |
2.6% |
|
| Interacting |
| Product Used For Unknown Indication |
100.0% |
|
| Neuropathy Peripheral |
100.0% |
|
